CPhI India will be releasing a comprehensive India pharma market report at CPhI India 2014. The report, conducted with the help of research partner Global Business Reports, will include thought-provoking analysis from key industry players – e.g. Cipla, Piramal, Sun, Lupin, Aurobindo and Biocon, Government bodies (IBEF/Pharmexcil) and explore new growth areas emerging across the country.
Now the tenth largest economy in the world and with global exports of around US$ 15 billion over the last 12 months, India is an innovation hub and a well-known focal point of the pharmaceutical industry and McKinsey and Company forecast a staggering total value of US$ 45 billion by 2020. Around 220 countries are sourcing pharma products from India, with the top 20 of India’s pharmaceutical companies contributing to almost two-thirds of the country’s total exports.
Those companies are further expected to increase capital expenditure (capex) by 40 per cent to over US$ 8.3 billion by 2017-18. India is constantly looking to increasingly match high quality Western standards, whilst maintaining lower manufacturing costs, showcasing the Indian pharma markets unique position and providing an optimum investment platform for international companies.
The CPhI India report will feature a robust analysis of the Indian pharma market and include significant contributions from 98 companies and all major Indian manufacturers, evaluating conditions for both foreign and domestic companies. Printed copies of the detailed 100+ page report will be available at CPhI India along with a media-ready version produced and launched to media at the event – including an overview of trends contained within the full report.
CPhI India will take place at the Bombay Convention and Exhibition Centre, Mumbai from December 2 to 4, 2014 and is expected to be attended by nearly 30,000 industry executives from over 95 countries. CPhI will be co-located with P-MEC India, ICSE India and BioPh as all sectors of the pharma industry attend this huge event.
This key global event is the perfect meeting place to network, observe trends and enhance new business opportunities. A series of technical seminars will take place throughout the show, providing detailed insights into current trends, issues and developments surrounding the pharma community, alongside the CPhI Pharma Awards India. A mobile app will be available to assist with navigation throughout CPhI India and provide easier access to all areas of the event.
Another new initiative is the introduction of the CPhI Global Angels charity campaign, which was first launched earlier this year at CPhI Worldwide. It is being rolled out across CPhI’s global portfolio and is designed to call on the pharma community to lend its support to this global charity that is transforming disadvantaged communities around the world.